YY1 is upregulated in various human cancers, including breast, bladder, cervical, colon, esophageal, liver, brain, and gastric cancers, and there is increasing evidence suggesting that it has pro-tumor consequences (Table 1) [25,26,27,28,29,30,31,32]. Here, YY1 is linked to neoplasm.